Investing.com - Vincerx Pharma (NASDAQ: VINC) reported third quarter EPS of $-0.68, $0.44 worse than the analyst estimate of $-0.24. Revenue for the quarter came in at $0 versus the consensus estimate of $0.
Vincerx Pharma's stock price closed at $1.66. It is up 32.80% in the last 3 months and down -22.79% in the last 12 months.
Vincerx Pharma saw positive EPS revisions and negative EPS revisions in the last 90 days. See Vincerx Pharma's stock price’s past reactions to earnings here.
According to InvestingPro, Vincerx Pharma's Financial Health score is "weak performance".
Check out Vincerx Pharma's recent earnings performance, and Vincerx Pharma's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar